SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: George Holt who wrote (1031)5/17/1998 6:15:00 PM
From: Sr K  Read Replies (1) of 2135
 
In some of today's articles are the statements:

At this time, it is not possible to produce the large quantities of endostatin or angiostatin necessary for human trials.

and, from the Chicago Tribune piece:

Folkman cautioned, however, that the trial could be delayed by ''unpredictable, imponderable things. For one thing, these proteins are hard to ship. They don't like dry ice. They like minus 20 degrees. It makes it really difficult to move them around.''
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News